Improvement of anemia after biologic therapies such as TCZ or TNF inhibitors has been reported previously in RA [5], [8], [11], and other inflammatory diseases such as Castleman's disease [9], [10]. The gene discussed is TNF; the disease is rheumatoid arthritis.